Published in J Hosp Infect on April 10, 2010
Candida bloodstream infections: comparison of species distributions and antifungal resistance patterns in community-onset and nosocomial isolates in the SENTRY Antimicrobial Surveillance Program, 2008-2009. Antimicrob Agents Chemother (2010) 1.61
Validation of a modified algorithm for the identification of yeast isolates using matrix-assisted laser desorption/ionisation time-of-flight mass spectrometry (MALDI-TOF MS). Eur J Clin Microbiol Infect Dis (2011) 1.38
Diagnostic issues, clinical characteristics, and outcomes for patients with fungemia. J Clin Microbiol (2011) 1.23
Prognostic factors and historical trends in the epidemiology of candidemia in critically ill patients: an analysis of five multicenter studies sequentially conducted over a 9-year period. Intensive Care Med (2014) 1.08
Waikialoid A suppresses hyphal morphogenesis and inhibits biofilm development in pathogenic Candida albicans. J Nat Prod (2012) 1.07
Species distribution and in vitro antifungal susceptibility profiles of yeast isolates from invasive infections during a Portuguese multicenter survey. Eur J Clin Microbiol Infect Dis (2014) 0.95
Small-molecule suppressors of Candida albicans biofilm formation synergistically enhance the antifungal activity of amphotericin B against clinical Candida isolates. ACS Chem Biol (2013) 0.84
Prospective observational multicenter study to define a diagnostic algorithm for biliary candidiasis. World J Gastroenterol (2014) 0.75
Epidemiology of Blood Stream Infection due to Candida Species in a Tertiary Care Hospital in Japan over 12 Years: Importance of Peripheral Line-Associated Candidemia. PLoS One (2016) 0.75
Vancomycin therapy for methicillin-resistant Staphylococcus aureus. Ann Intern Med (1982) 3.45
Extracellular phospholipase activity is a virulence factor for Cryptococcus neoformans. Mol Microbiol (2001) 3.02
Comparison of intravenous glucagon and dextrose in treatment of severe hypoglycemia in an accident and emergency department. Diabetes Care (1988) 2.61
Cryptococcal disease of the CNS in immunocompetent hosts: influence of cryptococcal variety on clinical manifestations and outcome. Clin Infect Dis (1995) 2.59
Antifungal agents for preventing fungal infections in non-neutropenic critically ill patients. Cochrane Database Syst Rev (2006) 2.13
Depression of immunological function in patients treated with phenytoin sodium (sodium diphenylhydantoin). Lancet (1971) 1.93
Phospholipase activity in Cryptococcus neoformans: a new virulence factor? J Infect Dis (1997) 1.72
A prospective study of adverse reactions associated with vancomycin therapy. J Antimicrob Chemother (1985) 1.64
Is semiquantitative culture of central vein catheter tips useful in the diagnosis of catheter-associated bacteremia? J Clin Microbiol (1986) 1.60
Campylobacter jejuni: incidence in processed broilers and biotype distribution in human and broiler isolates. Appl Environ Microbiol (1982) 1.56
Isolated hepatitis B core antibody--can response to hepatitis B vaccine help elucidate the cause? Aust N Z J Med (1992) 1.52
Inter-subject and ethnic differences in paracetamol metabolism. Br J Clin Pharmacol (1986) 1.48
Identification of extracellular phospholipase B, lysophospholipase, and acyltransferase produced by Cryptococcus neoformans. Infect Immun (1997) 1.45
Depression of immune competence by phenytoin and carbamazepine. Studies in vivo and in vitro. Clin Exp Immunol (1975) 1.40
Campylobacter jejuni in broilers: the role of vertical transmission. J Hyg (Lond) (1986) 1.38
Cryptococcosis: clinical and biological aspects. Med Mycol (2000) 1.35
Disseminated candidiasis: evidence of a distinctive syndrome in heroin abusers. Br Med J (Clin Res Ed) (1983) 1.31
Candidaemia with uncommon Candida species: predisposing factors, outcome, antifungal susceptibility, and implications for management. Clin Microbiol Infect (2009) 1.28
Evolution of resistance in Staphylococcus aureus in Australian teaching hospitals. Australian Group on Antimicrobial Resistance (AGAR). Med J Aust (1996) 1.26
Population-based surveillance for scedosporiosis in Australia: epidemiology, disease manifestations and emergence of Scedosporium aurantiacum infection. Clin Microbiol Infect (2009) 1.24
Cryptococcus neoformans var. gattii infection in northern Australia: existence of an environmental source other than known host eucalypts. Trans R Soc Trop Med Hyg (1998) 1.23
Candidemia following solid organ transplantation in the era of antifungal prophylaxis: the Australian experience. Transpl Infect Dis (2009) 1.22
Purification and characterization of secretory phospholipase B, lysophospholipase and lysophospholipase/transacylase from a virulent strain of the pathogenic fungus Cryptococcus neoformans. Biochem J (2000) 1.19
Susceptibility of Campylobacter jejuni to twenty-three antimicrobial agents. Pathology (1983) 1.18
Identification of pathogenic yeasts of the imperfect genus Candida by polymerase chain reaction fingerprinting. Electrophoresis (1997) 1.17
Methicillin-susceptible, non-multiresistant methicillin-resistant and multiresistant methicillin-resistant Staphylococcus aureus infections: a clinical, epidemiological and microbiological comparative study. Eur J Clin Microbiol Infect Dis (2008) 1.16
Characterization of Cryptococcus neoformans by random DNA amplification. Lett Appl Microbiol (1996) 1.15
Isolation of two molecular types of Cryptococcus neoformans var. gattii from insect frass. Med Mycol (2003) 1.14
Pancoast's syndrome due to pulmonary infection with Cryptococcus neoformans variety gattii. Clin Infect Dis (1992) 1.13
Comparison of use of phenotypic and genotypic characteristics for identification of species of the anamorph genus Candida and related teleomorph yeast species. J Clin Microbiol (1997) 1.12
HIV infection of monocytes inhibits the T-lymphocyte proliferative response to recall antigens, via production of eicosanoids. Immunology (1992) 1.12
Nasal carriage of Staphylococcus aureus, including community-associated methicillin-resistant strains, in Queensland adults. Clin Microbiol Infect (2009) 1.12
Better clinical decision making and reducing diagnostic error. J R Coll Physicians Edinb (2011) 1.10
Horizontal transmission of Campylobacter jejuni amongst broiler chicks: experimental studies. Epidemiol Infect (1990) 1.10
Heteronuclear NMR studies of metabolites produced by Cryptococcus neoformans in culture media: identification of possible virulence factors. Magn Reson Med (1999) 1.08
In-vitro effects of vancomycin, rifampicin, and fusidic acid, alone and in combination, against methicillin-resistant Staphylococcus aureus. J Antimicrob Chemother (1983) 1.06
Non-traumatic mycotic keratitis. Eye (Lond) (1992) 1.06
Mechanism of nonspecific macrophage-mediated cytotoxicity: evidence for lack of dependence upon oxygen. J Immunol (1978) 1.05
Biochemical and functional characterisation of secreted phospholipase activities from Cryptococcus neoformans in their naturally occurring state. J Med Microbiol (1999) 1.04
Influence of antibody affinity on the performance of different antibody assays. J Immunol Methods (1984) 1.03
Identification by random amplification of polymorphic DNA of a common molecular type of Cryptococcus neoformans var. neoformans in patients with AIDS or other immunosuppressive conditions. J Infect Dis (1996) 1.02
Skull-base osteomyelitis: fungal vs. bacterial infection. Clin Microbiol Infect (2011) 1.02
Cryptococcomas distinguished from gliomas with MR spectroscopy: an experimental rat and cell culture study. Radiology (2001) 1.02
Cellulitis due to Pseudomonas putrefaciens: possible production of exotoxins. Rev Infect Dis (1991) 1.02
Systemic sepsis and intravenous devices. A prospective survey. Med J Aust (1984) 1.01
Clinician response to Candida organisms in the urine of patients attending hospital. Eur J Clin Microbiol Infect Dis (2007) 1.01
Comparison of a multiplexed MassARRAY system with real-time allele-specific PCR technology for genotyping of methicillin-resistant Staphylococcus aureus. Clin Microbiol Infect (2011) 1.00
Detection of a vanB determinant in Enterococcus gallinarum in Australia. J Clin Microbiol (2000) 0.99
First outbreak of PVL-positive nonmultiresistant MRSA in a neonatal ICU in Australia: comparison of MALDI-TOF and SNP-plus-binary gene typing. Eur J Clin Microbiol Infect Dis (2010) 0.96
Leukotriene B4 omega-oxidation by human polymorphonuclear leukocytes is inhibited by pyocyanin, a phenazine derivative produced by Pseudomonas aeruginosa. Infect Immun (1992) 0.95
PCR fingerprinting: a convenient molecular tool to distinguish between Candida dubliniensis and Candida albicans. Med Mycol (2001) 0.94
A comparison of hospital and community-acquired infective endocarditis. Am J Cardiol (1992) 0.94
Experimental colonization of broiler chicks with Campylobacter jejuni. Epidemiol Infect (1988) 0.93
Recommendations for the treatment of established fungal infections. Intern Med J (2008) 0.93
Comparison of contamination rates of catheter-drawn and peripheral blood cultures. J Hosp Infect (2005) 0.92
Is the antimicrobial removal device a cost-effective addition to conventional blood cultures? J Clin Pathol (1984) 0.91
Detection and characterisation of extended spectrum beta-lactamases in Klebsiella pneumoniae causing nosocomial infection. Pathology (1998) 0.91
Isolation of Kingella kingae from a corneal ulcer. J Clin Microbiol (1992) 0.91
Partial sequence analysis of the actin gene and its potential for studying the phylogeny of Candida species and their teleomorphs. Int J Syst Evol Microbiol (2001) 0.91
Biliary sepsis. Reviewing treatment options. Drugs (1986) 0.90
Leptospirosis presenting as a haemorrhagic fever in a traveller from Africa. Med J Aust (1997) 0.90
A rapid slid coagglutination test-an alternative to the fluorescent antibody test for the identification of Neisseria gonorrhoeae. J Clin Pathol (1981) 0.90
Recombinant interleukin 4 stimulates human immunodeficiency virus production by infected monocytes and macrophages. J Gen Virol (1992) 0.90
Detection of occult Scedosporium species in respiratory tract specimens from patients with cystic fibrosis by use of selective media. J Clin Microbiol (2009) 0.89
Rhizopus and tongue depressors. Lancet (1996) 0.88
Chitotriosidase and gene therapy for fungal infections. Cell Mol Life Sci (2009) 0.88
Staphylococcus aureus 'Down Under': contemporary epidemiology of S. aureus in Australia, New Zealand, and the South West Pacific. Clin Microbiol Infect (2014) 0.88
Pseudomonas putrefaciens bacteraemia in a peritoneal dialysis patient. Nephrol Dial Transplant (1991) 0.86
Inhibition of platelet eicosanoid metabolism by the bacterial phenazine derivative pyocyanin. Ann N Y Acad Sci (1994) 0.86
Production of leukotriene B4 and 5-hydroxyeicosatetraenoic acid by human neutrophils is inhibited by Pseudomonas aeruginosa phenazine derivatives. Infect Immun (1991) 0.86
Adrenaline in treatment of septic shock: effects on haemodynamics and oxygen transport. Intensive Care Med (1991) 0.86
Amebic abscess of the spleen complicated by metronidazole-induced neurotoxicity: case report. Clin Infect Dis (1994) 0.85
Infection of vascular prostheses. Aust N Z J Surg (1991) 0.85
A rapid method for detecting extracellular proteinase activity in Cryptococcus neoformans and a survey of 63 isolates. J Med Microbiol (2000) 0.85
Real-time PCR detection and quantitation of Chlamydophila psittaci in human and avian specimens from a veterinary clinic cluster. Eur J Clin Microbiol Infect Dis (2008) 0.85
Varicella-zoster virus infection in Australia. Aust N Z J Public Health (1998) 0.84
Algal peritonitis complicating continuous ambulatory peritoneal dialysis. Am J Kidney Dis (1986) 0.84
Increases in Australian cutaneous abscess hospitalisations: 1999-2008. Eur J Clin Microbiol Infect Dis (2011) 0.84
Regulatory roles for the homeodomain and C2H2 zinc finger regions of Cryptococcus neoformans Ste12alphap. Mol Microbiol (2004) 0.83
Hemodynamic, renal, and hormonal actions of aprotinin in an ovine model of septic shock. Crit Care Med (1992) 0.83
The relationship of a clonal outbreak of Enterococcus faecium vanA to methicillin-resistant Staphylococcus aureus incidence in an Australian hospital. J Hosp Infect (2001) 0.82
Consensus guidelines for the treatment of yeast infections in the haematology, oncology and intensive care setting, 2014. Intern Med J (2014) 0.81
Systematic review and meta-analysis of antifungal agents for preventing fungal infections in liver transplant recipients. Eur J Clin Microbiol Infect Dis (2006) 0.81
Exogenous ocular candidiasis associated with intravenous heroin abuse. Br J Ophthalmol (1984) 0.81
Eicosapentaenoic acid modulates neutrophil leukotriene B4 receptor expression in cystic fibrosis. Clin Exp Immunol (1994) 0.81
Effect of pyocyanin and 1-hydroxyphenazine on the assay of lactate dehydrogenase activity. J Infect Dis (1991) 0.81
Molecular diagnostic methods for invasive fungal disease: the horizon draws nearer? Pathology (2015) 0.81
Modulation of neutrophil superoxide response and intracellular diacylglyceride levels by the bacterial pigment pyocyanin. Infect Immun (1997) 0.81
Molecular investigation of bacterial communities on the inner and outer surfaces of peripheral venous catheters. Eur J Clin Microbiol Infect Dis (2013) 0.81
In vitro interactions of neomycin sulfate, bacitracin, and polymyxin B sulfate. Int J Dermatol (1994) 0.80
Neurological toxicity associated with vidarabine (adenine arabinoside) therapy. Aust N Z J Med (1983) 0.80
Prevalence of Staphylococcus aureus strains in an Australian cohort, 1989-2003: evidence for the low prevalence of the toxic shock toxin and Panton-Valentine leukocidin genes. Eur J Clin Microbiol Infect Dis (2009) 0.80
GMP-140 (P-selectin) inhibits human neutrophil activation by lipopolysaccharide: analysis by proton magnetic resonance spectroscopy. Biochem Biophys Res Commun (1992) 0.80
Clinical significance of quantitative blood cultures in newborn infants. J Paediatr Child Health (1999) 0.80
Pneumonia with bacteraemia due to Escherichia coli. Aust N Z J Med (1981) 0.80
Divergent expression of cytotoxic and microbicidal functions of rabbit alveolar and peritoneal macrophages: effects of non-specific activation and a natural microbicidal peptide, MCP-1. Aust J Exp Biol Med Sci (1985) 0.79
Influenza-associated bacterial pathogens in patients with 2009 influenza A (H1N1) infection: impact of community-associated methicillin-resistant Staphylococcus aureus in Queensland, Australia. Intern Med J (2012) 0.79
The origin of 1H NMR-visible triacylglycerol in human neutrophils. Highfatty acid environments result in preferential sequestration of palmitic acid into plasma membrane triacylglycerol. Eur J Biochem (2000) 0.79
Antimicrobial therapy of postpartum endomyometritis. II. Prospective, randomized trial of mezlocillin versus ampicillin. Am J Obstet Gynecol (1981) 0.79